Sanofi and GlaxoSmithKline snag $2.1 billion funding from US govt in biggest coronavirus vaccine deal yet
The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion.
Pfizer CEO says COVID-19 vaccine likely to be ready by October this year; 'will have enough evidence of safety, efficacy'
Pfizer is working with German firm Biontech for several possible vaccines in Europe and the United States, said the report.
Sanofi will enroll thousands of subjects to participate in its Coronavirus vaccine trials in order to get data sooner
Late-stage trials with thousands of subjects comparing the vaccine to placebo are expected to take place by year-end or early 2021.
Unilever withdraws growth outlook; says India business impacted by slowing market, coronavirus-forced lockdown
Unilever witnessed a major impact on the businesses in China and India, two of its major markets where restrictions were imposed by the respective governments to contain the spread of COVID-19.
An important supplier of generic drugs to the world, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.
Apparently, a compound developed by GlaxoSmithKline can eliminate the mosquito-borne parasite in all the stages of its lifecycle.
The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer
Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch
Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.
GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses
GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare
A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company to the Netherlands
GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development
Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products
Unilever emerges as leading bidder in tight contest for GlaxoSmithKline's Horlicks nutrition business
GSK’s assets, which include the popular malt-based drinks Horlicks and Boost, is likely to fetch less than $4 billion, said people close the deal
Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion
Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK
Glenmark said it has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.
GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.
The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment.
Sun Pharmaceutical Industries, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia.
Lupin has inked a pact with Poland-based Celon Pharma to jointly develop and market a generic version GlaxoSmithKline's Advair Diskus, a drug used to treat asthama, in global markets.
Many of the jobs lost will be from GSK's Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London.<br />
Researchers assess the effectiveness of candidate vaccines by whether they trigger production of anti-Ebola antibodies and immune-system T cells.